4559.T
4559.T
JP3428850006
ZERIA PHARMACEUTICAL
Loading chart...

Company Profile

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; and non-steroidal anti-inflammatory ophthalmic solutions. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. Further, the company engages in insurance agency and real estate business. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.

Related stocks

4534.T
4534.T • Japan
MOCHIDA PHARMACEUTICAL CO
3,075 JPY
682.51M USD 1Y -1.6%
4553.T
4553.T • Japan
TOWA PHARMACEUTICAL CO
3,620 JPY
1.13B USD 1Y +21.7%
4547.T
4547.T • Japan
KISSEI PHARMACEUTICAL CO
3,710 JPY
981.04M USD 1Y -13.4%
4521.T
4521.T • Japan
KAKEN PHARMACEUTICAL
3,705 JPY
886.61M USD 1Y -1.1%
000078.SZ
000078.SZ • China
NEPTUNUS
1.46 CNY
574.81M USD 1Y -41.8%
4105.TWO
4105.TWO • Taiwan
TTY BIOPHARM COMPANY LIMITED
80.9 TWD
630.39M USD 1Y +0.6%
FDC.BO
FDC.BO • India
FDC LTD.
330.1 INR
555.32M USD 1Y -27.9%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

6/7 High
5Y Volatility
20.9% p.a.
Max Drawdown (5Y)
-27.3%
Sharpe Ratio (5Y)
-0.17
Beta Factor
0.06
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende